Pfizer Says COVID-19 Vaccine Shows '100% Efficacy' In Adolescents



New clinical trials showed that Pfizer's COVID-19 vaccine elicits "100% efficacy and robust antibody responses" in adolescents from 12 to 15 years old, the drug company announced Wednesday. The trial included 2,260 participants; the results are even better than earlier responses from participants ages 16 to 25. Nice!


Read more about it


Photo Credit: Franck

16 views0 comments